{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:11:39Z","timestamp":1789197099044,"version":"build-2803163510"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Preliminary Fund Project of The Second Affiliated Hospital of Soochow University","award":["SDFEYBS2423"],"award-info":[{"award-number":["SDFEYBS2423"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04434-9","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:44:40Z","timestamp":1785905080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of fusion genes in breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhuo","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"4434_CR1","doi-asserted-by":"publisher","first-page":"175883592211441","DOI":"10.1177\/17588359221144108","volume":"14","author":"M Sorokin","year":"2022","unstructured":"Sorokin M, Rabushko E, Rozenberg JM, Mohammad T, Seryakov A, Sekacheva M, Buzdin A. Clinically relevant fusion oncogenes: detection and practical implications. Ther Adv Med Oncol. 2022;14:17588359221144108. https:\/\/doi.org\/10.1177\/17588359221144108.","journal-title":"Ther Adv Med Oncol"},{"key":"4434_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","volume":"23","author":"Q Gao","year":"2018","unstructured":"Gao Q, Liang WW, Foltz SM, Mutharasu G, Jayasinghe RG, Cao S, Liao WW, Reynolds SM, Wyczalkowski MA, Yao L, Yu L, Sun SQ, Chen K, Lazar AJ, Fields RC, Wendl MC, Van Tine BA, Vij R, Chen F, Nykter M, Shmulevich I, Ding L. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep. 2018;23:227\u2013e2383. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.050.","journal-title":"Cell Rep"},{"key":"4434_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4434_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13256-021-02876-5","volume":"15","author":"H Hu","year":"2021","unstructured":"Hu H, Ding N, Zhou H, Wang S, Tang L, Xiao Z. A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report. J Med Case Rep. 2021;15:277. https:\/\/doi.org\/10.1186\/s13256-021-02876-5.","journal-title":"J Med Case Rep"},{"key":"4434_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00428-023-03500-1","volume":"483","author":"T Lei","year":"2023","unstructured":"Lei T, Shi Y, Da W, Xia C, Wang H. A novel EWSR1-MYB fusion in an aggressive advanced breast adenoid cystic carcinoma with mixed classical and solid-basaloid components. Virchows Arch. 2023;483:717\u201322. https:\/\/doi.org\/10.1007\/s00428-023-03500-1.","journal-title":"Virchows Arch"},{"key":"4434_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s1535-6108(02)00180-0","volume":"2","author":"C Tognon","year":"2002","unstructured":"Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PH. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367\u201376. https:\/\/doi.org\/10.1016\/s1535-6108(02)00180-0.","journal-title":"Cancer Cell"},{"key":"4434_CR7","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.1073\/pnas.0909114106","volume":"106","author":"M Persson","year":"2009","unstructured":"Persson M, Andr\u00e9n Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009;106:18740\u20134. https:\/\/doi.org\/10.1073\/pnas.0909114106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4434_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/gcc.22533","volume":"57","author":"D Fimereli","year":"2018","unstructured":"Fimereli D, Fumagalli D, Brown D, Gacquer D, Roth\u00e9 F, Salgado R, Larsimont D, Sotiriou C, Detours V. Genomic hotspots but few recurrent fusion genes in breast cancer. Genes Chromosomes Cancer. 2018;57:331\u20138. https:\/\/doi.org\/10.1002\/gcc.22533.","journal-title":"Genes Chromosomes Cancer"},{"key":"4434_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1755-8794-4-75","volume":"4","author":"KC Ha","year":"2011","unstructured":"Ha KC, Lalonde E, Li L, Cavallone L, Natrajan R, Lambros MB, Mitsopoulos C, Hakas J, Kozarewa I, Fenwick K, Lord CJ, Ashworth A, Vincent-Salomon A, Basik M, Reis-Filho JS, Majewski J, Foulkes WD. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines. BMC Med Genomics. 2011;4:75. https:\/\/doi.org\/10.1186\/1755-8794-4-75.","journal-title":"BMC Med Genomics"},{"key":"4434_CR10","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.humpath.2014.07.013","volume":"45","author":"TM D\u2019Alfonso","year":"2014","unstructured":"D\u2019Alfonso TM, Mosquera JM, MacDonald TY, Padilla J, Liu YF, Rubin MA, Shin SJ. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features. Hum Pathol. 2014;45:2270\u201380. https:\/\/doi.org\/10.1016\/j.humpath.2014.07.013.","journal-title":"Hum Pathol"},{"key":"4434_CR11","doi-asserted-by":"publisher","first-page":"9912","DOI":"10.1073\/pnas.1921333117","volume":"117","author":"S Lee","year":"2020","unstructured":"Lee S, Hu Y, Loo SK, Tan Y, Bhargava R, Lewis MT, Wang XS. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer. Proc Natl Acad Sci U S A. 2020;117:9912\u201321. https:\/\/doi.org\/10.1073\/pnas.1921333117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4434_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13058-020-01377-5","volume":"23","author":"KD Howarth","year":"2021","unstructured":"Howarth KD, Mirza T, Cooke SL, Chin SF, Pole JC, Turro E, Eldridge MD, Garcia RM, Rueda OM, Boursnell C, Abraham JE, Caldas C, Edwards PAW. NRG1 fusions in breast cancer. Breast Cancer Res. 2021;23:3. https:\/\/doi.org\/10.1186\/s13058-020-01377-5.","journal-title":"Breast Cancer Res"},{"key":"4434_CR13","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1038\/ncomms5577","volume":"5","author":"J Veeraraghavan","year":"2014","unstructured":"Veeraraghavan J, Tan Y, Cao XX, Kim JA, Wang X, Chamness GC, Maiti SN, Cooper LJ, Edwards DP, Contreras A, Hilsenbeck SG, Chang EC, Schiff R, Wang XS. Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers. Nat Commun. 2014;5:4577. https:\/\/doi.org\/10.1038\/ncomms5577.","journal-title":"Nat Commun"},{"key":"4434_CR14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/his.14461","volume":"79","author":"S Ma","year":"2021","unstructured":"Ma S, Zhao D, Liu Y, Rohr J, Zhang F, Ma Y, Gong L, Shi H, Wang Y, Fan L, Qin J, Wang Z, Guo S. Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands. Histopathology. 2021;79:1030\u20139. https:\/\/doi.org\/10.1111\/his.14461.","journal-title":"Histopathology"},{"key":"4434_CR15","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.Can-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"Jones DT, Kocialkowski S, Liu L, Pearson DM, B\u00e4cklund LM, Ichimura K, Collins VP. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008;68:8673\u20137. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-2097.","journal-title":"Cancer Res"},{"key":"4434_CR16","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1158\/0008-5472.Can-20-1920","volume":"80","author":"M Bolkestein","year":"2020","unstructured":"Bolkestein M, Wong JKL, Thewes V, K\u00f6rber V, Hlevnjak M, Elgaafary S, Schulze M, Kommoss FKF, Sinn HP, Anzeneder T, Hirsch S, Devens F, Schr\u00f6ter P, H\u00f6fer T, Schneeweiss A, Lichter P, Zapatka M, Ernst A. Chromothripsis in Human Breast Cancer. Cancer Res. 2020;80:4918\u201331. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-1920.","journal-title":"Cancer Res"},{"key":"4434_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1126\/science.1156725","volume":"321","author":"H Li","year":"2008","unstructured":"Li H, Wang J, Mor G, Sklar J. A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science. 2008;321:1357\u201361. https:\/\/doi.org\/10.1126\/science.1156725.","journal-title":"Science"},{"key":"4434_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10549-014-3019-2","volume":"146","author":"KE Varley","year":"2014","unstructured":"Varley KE, Gertz J, Roberts BS, Davis NS, Bowling KM, Kirby MK, Nesmith AS, Oliver PG, Grizzle WE, Forero A, Buchsbaum DJ, LoBuglio AF, Myers RM. Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Res Treat. 2014;146:287\u201397. https:\/\/doi.org\/10.1007\/s10549-014-3019-2.","journal-title":"Breast Cancer Res Treat"},{"key":"4434_CR19","doi-asserted-by":"publisher","first-page":"682021","DOI":"10.3389\/fonc.2021.682021","volume":"11","author":"MY Wang","year":"2021","unstructured":"Wang MY, Huang M, Wang CY, Tang XY, Wang JG, Yang YD, Xiong X, Gao CW. Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer. Front Oncol. 2021;11:682021. https:\/\/doi.org\/10.3389\/fonc.2021.682021.","journal-title":"Front Oncol"},{"key":"4434_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1158\/1078-0432.Ccr-20-2769","volume":"27","author":"CC Liu","year":"2021","unstructured":"Liu CC, Veeraraghavan J, Tan Y, Kim JA, Wang X, Loo SK, Lee S, Hu Y, Wang XS. A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4, Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers. Clin Cancer Res. 2021;27:785\u201398. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-2769.","journal-title":"Clin Cancer Res"},{"key":"4434_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/gcc.22279","volume":"54","author":"J Kim","year":"2015","unstructured":"Kim J, Kim S, Ko S, In YH, Moon HG, Ahn SK, Kim MK, Lee M, Hwang JH, Ju YS, Kim JI, Noh DY, Kim S, Park JH, Rhee H, Kim S, Han W. Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples. Genes Chromosomes Cancer. 2015;54:681\u201391. https:\/\/doi.org\/10.1002\/gcc.22279.","journal-title":"Genes Chromosomes Cancer"},{"key":"4434_CR22","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1158\/0008-5472.Can-11-3142","volume":"72","author":"YW Asmann","year":"2012","unstructured":"Asmann YW, Necela BM, Kalari KR, Hossain A, Baker TR, Carr JM, Davis C, Getz JE, Hostetter G, Li X, McLaughlin SA, Radisky DC, Schroth GP, Cunliffe HE, Perez EA, Thompson EA. Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer. Cancer Res. 2012;72:1921\u20138. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-3142.","journal-title":"Cancer Res"},{"key":"4434_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, Xiao Y, Yu KD, Liu YR, Yu Y, Zheng Y, Li X, Zhang C, Hu P, Zhang J, Hua Q, Zhang J, Hou W, Ren L, Bao D, Li B, Yang J, Yao L, Zuo WJ, Zhao S, Gong Y, Ren YX, Zhao YX, Yang YS, Niu Z, Cao ZG, Stover DG, Verschraegen C, Kaklamani V, Daemen A, Benson JR, Takabe K, Bai F, Li DQ, Wang P, Shi L, Huang W, Shao ZM. Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell. 2019;35:428\u2013e4405. https:\/\/doi.org\/10.1016\/j.ccell.2019.02.001.","journal-title":"Cancer Cell"},{"key":"4434_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/path.5006","volume":"244","author":"J Kim","year":"2018","unstructured":"Kim J, Geyer FC, Martelotto LG, Ng CK, Lim RS, Selenica P, Li A, Pareja F, Fusco N, Edelweiss M, Kumar R, Gularte-Merida R, Forbes AN, Khurana E, Mariani O, Badve S, Vincent-Salomon A, Norton L, Reis-Filho JS, Weigelt B. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene. J Pathol. 2018;244:143\u201350. https:\/\/doi.org\/10.1002\/path.5006.","journal-title":"J Pathol"},{"key":"4434_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41523-020-0164-0","volume":"6","author":"F Pareja","year":"2020","unstructured":"Pareja F, Da Cruz Paula A, Gularte-M\u00e9rida R, Vahdatinia M, Li A, Geyer FC, da Silva EM, Nanjangud G, Wen HY, Varga Z, Brogi E, Rakha EA, Weigelt B, Reis-Filho JS. Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes. NPJ Breast Cancer. 2020;6:20. https:\/\/doi.org\/10.1038\/s41523-020-0164-0.","journal-title":"NPJ Breast Cancer"},{"key":"4434_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/his.13779","volume":"74","author":"GR Bean","year":"2019","unstructured":"Bean GR, Krings G, Otis CN, Solomon DA, Garc\u00eda JJ, van Zante A, Camelo-Piragua S, van Ziffle J, Chen YY. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast. Histopathology. 2019;74:463\u201373. https:\/\/doi.org\/10.1111\/his.13779.","journal-title":"Histopathology"},{"key":"4434_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12885-022-09265-1","volume":"22","author":"SR Vitale","year":"2022","unstructured":"Vitale SR, Ruigrok-Ritstier K, Timmermans AM, Foekens R, Trapman-Jansen A, Beaufort CM, Vigneri P, Sleijfer S, Martens JWM, Sieuwerts AM, Jansen M. The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer. BMC Cancer. 2022;22:165. https:\/\/doi.org\/10.1186\/s12885-022-09265-1.","journal-title":"BMC Cancer"},{"key":"4434_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2018.04.020","volume":"428","author":"J Jung","year":"2018","unstructured":"Jung J, Jang K, Ju JM, Lee E, Lee JW, Kim HJ, Kim J, Lee SB, Ko BS, Son BH, Lee HJ, Gong G, Ahn SY, Choi JK, Singh SR, Chang S. Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model. Cancer Lett. 2018;428:127\u201338. https:\/\/doi.org\/10.1016\/j.canlet.2018.04.020.","journal-title":"Cancer Lett"},{"key":"4434_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/jnci\/djy216","volume":"111","author":"F Pareja","year":"2019","unstructured":"Pareja F, Lee JY, Brown DN, Piscuoglio S, Gularte-M\u00e9rida R, Selenica P, Da Cruz Paula A, Arunachalam S, Kumar R, Geyer FC, Silveira C, da Silva EM, Li A, Marchi\u00f2 C, Ng CKY, Mariani O, Fuhrmann L, Wen HY, Norton L, Vincent-Salomon A, Brogi E, Reis-Filho JS, Weigelt B. The Genomic Landscape of Mucinous Breast Cancer. J Natl Cancer Inst. 2019;111:737\u201341. https:\/\/doi.org\/10.1093\/jnci\/djy216.","journal-title":"J Natl Cancer Inst"},{"key":"4434_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1101\/gr.113225.110","volume":"21","author":"K Inaki","year":"2011","unstructured":"Inaki K, Hillmer AM, Ukil L, Yao F, Woo XY, Vardy LA, Zawack KF, Lee CW, Ariyaratne PN, Chan YS, Desai KV, Bergh J, Hall P, Putti TC, Ong WL, Shahab A, Cacheux-Rataboul V, Karuturi RK, Sung WK, Ruan X, Bourque G, Ruan Y, Liu ET. Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Res. 2011;21:676\u201387. https:\/\/doi.org\/10.1101\/gr.113225.110.","journal-title":"Genome Res"},{"key":"4434_CR31","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41598-019-38550-6","volume":"9","author":"YP Yu","year":"2019","unstructured":"Yu YP, Liu P, Nelson J, Hamilton RL, Bhargava R, Michalopoulos G, Chen Q, Zhang J, Ma D, Pennathur A, Luketich J, Nalesnik M, Tseng G, Luo JH. Identification of recurrent fusion genes across multiple cancer types. Sci Rep. 2019;9:1074. https:\/\/doi.org\/10.1038\/s41598-019-38550-6.","journal-title":"Sci Rep"},{"key":"4434_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.lungcan.2019.03.018","volume":"131","author":"C Lin","year":"2019","unstructured":"Lin C, Shi X, Yang S, Zhao J, He Q, Jin Y, Yu X. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer. Lung Cancer. 2019;131:62\u20138. https:\/\/doi.org\/10.1016\/j.lungcan.2019.03.018.","journal-title":"Lung Cancer"},{"key":"4434_CR33","doi-asserted-by":"publisher","first-page":"e0117032","DOI":"10.1371\/journal.pone.0117032","volume":"10","author":"L Liu","year":"2015","unstructured":"Liu L, Zhan P, Zhou X, Song Y, Zhou X, Yu L, Wang J. Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods. PLoS ONE. 2015;10:e0117032. https:\/\/doi.org\/10.1371\/journal.pone.0117032.","journal-title":"PLoS ONE"},{"key":"4434_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3978\/j.issn.2218-6751.2014.02.02","volume":"3","author":"C Teixid\u00f3","year":"2014","unstructured":"Teixid\u00f3 C, Karachaliou N, Peg V, Gimenez-Capitan A, Rosell R. Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements. Transl Lung Cancer Res. 2014;3:70\u20134. https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2014.02.02.","journal-title":"Transl Lung Cancer Res"},{"key":"4434_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cncy.21510","volume":"123","author":"W Wang","year":"2015","unstructured":"Wang W, Tang Y, Li J, Jiang L, Jiang Y, Su X. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization. Cancer Cytopathol. 2015;123:117\u201322. https:\/\/doi.org\/10.1002\/cncy.21510.","journal-title":"Cancer Cytopathol"},{"key":"4434_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5858\/arpa.2011-0321-OA","volume":"136","author":"ML Wallander","year":"2012","unstructured":"Wallander ML, Geiersbach KB, Tripp SR, Layfield LJ. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing. Arch Pathol Lab Med. 2012;136:796\u2013803. https:\/\/doi.org\/10.5858\/arpa.2011-0321-OA.","journal-title":"Arch Pathol Lab Med"},{"key":"4434_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/cjp2.324","volume":"9","author":"F Zito Marino","year":"2023","unstructured":"Zito Marino F, Buono S, Montella M, Giannatiempo R, Messina F, Casaretta G, Arpino G, Vita G, Fiorentino F, Insabato L, Sgambato A, Orditura M, Franco R, Accardo M. NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS. J Pathol Clin Res. 2023;9:367\u201377. https:\/\/doi.org\/10.1002\/cjp2.324.","journal-title":"J Pathol Clin Res"},{"key":"4434_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13059-024-03324-5","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu Z, Xie Z, Li M. Comprehensive and deep evaluation of structural variation detection pipelines with third-generation sequencing data. Genome Biol. 2024;25:188. https:\/\/doi.org\/10.1186\/s13059-024-03324-5.","journal-title":"Genome Biol"},{"key":"4434_CR39","doi-asserted-by":"publisher","unstructured":"Dorney R, Dhungel BP, Rasko JEJ, Hebbard L, Schmitz U. Recent advances in cancer fusion transcript detection. Brief Bioinform. 2023;24. https:\/\/doi.org\/10.1093\/bib\/bbac519.","DOI":"10.1093\/bib\/bbac519"},{"key":"4434_CR40","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/gb-2010-11-10-r104","volume":"11","author":"A Sboner","year":"2010","unstructured":"Sboner A, Habegger L, Pflueger D, Terry S, Chen DZ, Rozowsky JS, Tewari AK, Kitabayashi N, Moss BJ, Chee MS, Demichelis F, Rubin MA, Gerstein MB. FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biol. 2010;11:R104. https:\/\/doi.org\/10.1186\/gb-2010-11-10-r104.","journal-title":"Genome Biol"},{"key":"4434_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21147\/j.issn.1000-9604.2017.05.01","volume":"29","author":"R Inaki","year":"2017","unstructured":"Inaki R, Abe M, Zong L, Abe T, Shinozaki-Ushiku A, Ushiku T, Hoshi K. Secretory carcinoma - impact of translocation and gene fusions on salivary gland tumor. Chin J Cancer Res. 2017;29:379\u201384. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2017.05.01.","journal-title":"Chin J Cancer Res"},{"key":"4434_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.semcancer.2005.01.003","volume":"15","author":"CL Lannon","year":"2005","unstructured":"Lannon CL, Sorensen PH. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol. 2005;15:215\u201323. https:\/\/doi.org\/10.1016\/j.semcancer.2005.01.003.","journal-title":"Semin Cancer Biol"},{"key":"4434_CR43","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/s41388-017-0102-2","volume":"37","author":"J Park","year":"2018","unstructured":"Park J, Kim J, Park B, Yang KM, Sun EJ, Tognon CE, Sorensen PH, Kim SJ. Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis. Oncogene. 2018;37:2270\u201384. https:\/\/doi.org\/10.1038\/s41388-017-0102-2.","journal-title":"Oncogene"},{"key":"4434_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature11154","volume":"486","author":"S Banerji","year":"2012","unstructured":"Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, Cortes ML, Fernandez-Lopez JC, Peng S, Ardlie KG, Auclair D, Bautista-Pi\u00f1a V, Duke F, Francis J, Jung J, Maffuz-Aziz A, Onofrio RC, Parkin M, Pho NH, Quintanar-Jurado V, Ramos AH, Rebollar-Vega R, Rodriguez-Cuevas S, Romero-Cordoba SL, Schumacher SE, Stransky N, Thompson KM, Uribe-Figueroa L, Baselga J, Beroukhim R, Polyak K, Sgroi DC, Richardson AL, Jimenez-Sanchez G, Lander ES, Gabriel SB, Garraway LA, Golub TR, Melendez-Zajgla J, Toker A, Getz G, Hidalgo-Miranda A, Meyerson M. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012;486:405\u20139. https:\/\/doi.org\/10.1038\/nature11154.","journal-title":"Nature"},{"key":"4434_CR45","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.celrep.2013.08.022","volume":"4","author":"S Li","year":"2013","unstructured":"Li S, Shen D, Shao J, Crowder R, Liu W, Prat A, He X, Liu S, Hoog J, Lu C, Ding L, Griffith OL, Miller C, Larson D, Fulton RS, Harrison M, Mooney T, McMichael JF, Luo J, Tao Y, Goncalves R, Schlosberg C, Hiken JF, Saied L, Sanchez C, Giuntoli T, Bumb C, Cooper C, Kitchens RT, Lin A, Phommaly C, Davies SR, Zhang J, Kavuri MS, McEachern D, Dong YY, Ma C, Pluard T, Naughton M, Bose R, Suresh R, McDowell R, Michel L, Aft R, Gillanders W, DeSchryver K, Wilson RK, Wang S, Mills GB, Gonzalez-Angulo A, Edwards JR, Maher C, Perou CM, Mardis ER, Ellis MJ. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep. 2013;4:1116\u201330. https:\/\/doi.org\/10.1016\/j.celrep.2013.08.022.","journal-title":"Cell Rep"},{"key":"4434_CR46","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/molbev\/msn165","volume":"25","author":"YC Lin","year":"2008","unstructured":"Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo WL, Yu AL. c-Myb is an evolutionary conserved miR-150 target and miR-150\/c-Myb interaction is important for embryonic development. Mol Biol Evol. 2008;25:2189\u201398. https:\/\/doi.org\/10.1093\/molbev\/msn165.","journal-title":"Mol Biol Evol"},{"key":"4434_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/path.4325","volume":"232","author":"R Natrajan","year":"2014","unstructured":"Natrajan R, Wilkerson PM, Marchi\u00f2 C, Piscuoglio S, Ng CK, Wai P, Lambros MB, Samartzis EP, Dedes KJ, Frankum J, Bajrami I, Kopec A, Mackay A, A\u2019Hern R, Fenwick K, Kozarewa I, Hakas J, Mitsopoulos C, Hardisson D, Lord CJ, Kumar-Sinha C, Ashworth A, Weigelt B, Sapino A, Chinnaiyan AM, Maher CA, Reis-Filho JS. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol. 2014;232:553\u201365. https:\/\/doi.org\/10.1002\/path.4325.","journal-title":"J Pathol"},{"key":"4434_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41417-021-00301-z","volume":"29","author":"A Hu","year":"2022","unstructured":"Hu A, Hong F, Li D, Xie Q, Chen K, Zhu L, He H. KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT\/\u03b2-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma. Cancer Gene Ther. 2022;29:215\u201324. https:\/\/doi.org\/10.1038\/s41417-021-00301-z.","journal-title":"Cancer Gene Ther"},{"key":"4434_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41523-018-0101-7","volume":"5","author":"F Pareja","year":"2019","unstructured":"Pareja F, Geyer FC, Brown DN, Sebasti\u00e3o APM, Gularte-M\u00e9rida R, Li A, Edelweiss M, Da Cruz Paula A, Selenica P, Wen HY, Jungbluth AA, Varga Z, Palazzo J, Rubin BP, Ellis IO, Brogi E, Rakha EA, Weigelt B, Reis-Filho JS. Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas. NPJ Breast Cancer. 2019;5:6. https:\/\/doi.org\/10.1038\/s41523-018-0101-7.","journal-title":"NPJ Breast Cancer"},{"key":"4434_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","volume":"21","author":"J Sukumar","year":"2021","unstructured":"Sukumar J, Gast K, Quiroga D, Lustberg M, Williams N. Triple-negative breast cancer: promising prognostic biomarkers currently in development. Expert Rev Anticancer Ther. 2021;21:135\u201348. https:\/\/doi.org\/10.1080\/14737140.2021.1840984.","journal-title":"Expert Rev Anticancer Ther"},{"key":"4434_CR51","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.pathol.2023.05.002","volume":"55","author":"MA Nguyen","year":"2023","unstructured":"Nguyen MA, Colebatch AJ, Van Beek D, Tierney G, Gupta R, Cooper WA. NTRK fusions in solid tumours: what every pathologist needs to know. Pathology. 2023;55:596\u2013609. https:\/\/doi.org\/10.1016\/j.pathol.2023.05.002.","journal-title":"Pathology"},{"key":"4434_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cancergen.2022.01.004","volume":"262\u2013263","author":"ER Blauel","year":"2022","unstructured":"Blauel ER, Laetsch TW. The promise of TRK inhibitors in pediatric cancers with NTRK fusions. Cancer Genet. 2022;262\u2013263:71\u20139. https:\/\/doi.org\/10.1016\/j.cancergen.2022.01.004.","journal-title":"Cancer Genet"},{"key":"4434_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.apsb.2020.05.004","volume":"11","author":"T Jiang","year":"2021","unstructured":"Jiang T, Wang G, Liu Y, Feng L, Wang M, Liu J, Chen Y, Ouyang L. Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. Acta Pharm Sin B. 2021;11:355\u201372. https:\/\/doi.org\/10.1016\/j.apsb.2020.05.004.","journal-title":"Acta Pharm Sin B"},{"key":"4434_CR54","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1002\/cncr.31701","volume":"124","author":"SG DuBois","year":"2018","unstructured":"DuBois SG, Laetsch TW, Federman N, Turpin BK, Albert CM, Nagasubramanian R, Anderson ME, Davis JL, Qamoos HE, Reynolds ME, Cruickshank S, Cox MC, Hawkins DS, Mascarenhas L, Pappo AS. The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas. Cancer. 2018;124:4241\u20137. https:\/\/doi.org\/10.1002\/cncr.31701.","journal-title":"Cancer"},{"key":"4434_CR55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s1470-2045(19)30856-3","volume":"21","author":"DS Hong","year":"2020","unstructured":"Hong DS, DuBois SG, Kummar S, Farago AF, Albert CM, Rohrberg KS, van Tilburg CM, Nagasubramanian R, Berlin JD, Federman N, Mascarenhas L, Geoerger B, Dowlati A, Pappo AS, Bielack S, Doz F, McDermott R, Patel JD, Schilder RJ, Tahara M, Pfister SM, Witt O, Ladanyi M, Rudzinski ER, Nanda S, Childs BH, Laetsch TW, Hyman DM, Drilon A. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol. 2020;21:531\u201340. https:\/\/doi.org\/10.1016\/s1470-2045(19)30856-3.","journal-title":"Lancet Oncol"},{"key":"4434_CR56","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1093\/oncolo\/oyad115","volume":"28","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu W, Zhuo X, Liu L, Zhang J, Jiang F, Shen Y, Lei Y, Hou D, Lin X, Wang C, Fu G. Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation. Oncologist. 2023;28:e416\u201324. https:\/\/doi.org\/10.1093\/oncolo\/oyad115.","journal-title":"Oncologist"},{"key":"4434_CR57","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1038\/s41467-018-07341-4","volume":"9","author":"BS Paratala","year":"2018","unstructured":"Paratala BS, Chung JH, Williams CB, Yilmazel B, Petrosky W, Williams K, Schrock AB, Gay LM, Lee E, Dolfi SC, Pham K, Lin S, Yao M, Kulkarni A, DiClemente F, Liu C, Rodriguez-Rodriguez L, Ganesan S, Ross JS, Ali SM, Leyland-Jones B, Hirshfield KM. RET rearrangements are actionable alterations in breast cancer. Nat Commun. 2018;9:4821. https:\/\/doi.org\/10.1038\/s41467-018-07341-4.","journal-title":"Nat Commun"},{"key":"4434_CR58","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1158\/0008-5472.Can-22-3484","volume":"83","author":"X Gou","year":"2023","unstructured":"Gou X, Kim BJ, Anurag M, Lei JT, Young MN, Holt MV, Fandino D, Vollert CT, Singh P, Alzubi MA, Malovannaya A, Dobrolecki LE, Lewis MT, Li S, Foulds CE, Ellis MJ. Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023;83:3237\u201351. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-3484.","journal-title":"Cancer Res"},{"key":"4434_CR59","doi-asserted-by":"publisher","first-page":"e2200702","DOI":"10.1200\/po.22.00702","volume":"7","author":"E Nicol\u00f2","year":"2023","unstructured":"Nicol\u00f2 E, Munoz-Arcos L, Vagia E, D\u2019Amico P, Reduzzi C, Donahue J, Lorico-Rappa M, Manai M, Behdad A, Zhang Y, Curigliano G, Shah A, Cristofanilli M. Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of FGFR2-KIAA1598 Gene Fusion. JCO Precis Oncol. 2023;7:e2200702. https:\/\/doi.org\/10.1200\/po.22.00702.","journal-title":"JCO Precis Oncol"},{"key":"4434_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12964-019-0486-4","volume":"18","author":"NJ Chew","year":"2020","unstructured":"Chew NJ, Nguyen EV, Su SP, Novy K, Chan HC, Nguyen LK, Luu J, Simpson KJ, Lee RS, Daly RJ. FGFR3 signaling and function in triple negative breast cancer. Cell Commun Signal. 2020;18:13. https:\/\/doi.org\/10.1186\/s12964-019-0486-4.","journal-title":"Cell Commun Signal"},{"key":"4434_CR61","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.18632\/oncotarget.3296","volume":"6","author":"WY Leung","year":"2015","unstructured":"Leung WY, Roxanis I, Sheldon H, Buffa FM, Li JL, Harris AL, Kong A. Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer. Oncotarget. 2015;6:5678\u201394. https:\/\/doi.org\/10.18632\/oncotarget.3296.","journal-title":"Oncotarget"},{"key":"4434_CR62","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1158\/1078-0432.Ccr-20-3605","volume":"27","author":"I Odintsov","year":"2021","unstructured":"Odintsov I, Lui AJW, Sisso WJ, Gladstone E, Liu Z, Delasos L, Kurth RI, Sisso EM, Vojnic M, Khodos I, Mattar MS, de Stanchina E, Leland SM, Ladanyi M, Somwar R. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions. Clin Cancer Res. 2021;27:3154\u201366. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-3605.","journal-title":"Clin Cancer Res"},{"key":"4434_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbrc.2012.10.087","volume":"429","author":"HT Chi","year":"2012","unstructured":"Chi HT, Ly BT, Kano Y, Tojo A, Watanabe T, Sato Y. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412. Biochem Biophys Res Commun. 2012;429:87\u201392. https:\/\/doi.org\/10.1016\/j.bbrc.2012.10.087.","journal-title":"Biochem Biophys Res Commun"},{"key":"4434_CR64","doi-asserted-by":"publisher","unstructured":"Andersson MK, Afshari MK, Andr\u00e9n Y, Wick MJ, Stenman G. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R\/AKT Signaling. J Natl Cancer Inst. 2017;109. https:\/\/doi.org\/10.1093\/jnci\/djx017.","DOI":"10.1093\/jnci\/djx017"},{"key":"4434_CR65","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/oncolo\/oyac248","volume":"28","author":"JO Brett","year":"2023","unstructured":"Brett JO, Ritterhouse LL, Newman ET, Irwin KE, Dawson M, Ryan LY, Spring LM, Rivera MN, Lennerz JK, Dias-Santagata D, Ellisen LW, Bardia A, Wander SA. Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series. Oncologist. 2023;28:172\u20139. https:\/\/doi.org\/10.1093\/oncolo\/oyac248.","journal-title":"Oncologist"},{"key":"4434_CR66","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1038\/s41388-018-0284-2","volume":"37","author":"LA Gates","year":"2018","unstructured":"Gates LA, Gu G, Chen Y, Rohira AD, Lei JT, Hamilton RA, Yu Y, Lonard DM, Wang J, Wang SP, Edwards DG, Lavere PF, Shao J, Yi P, Jain A, Jung SY, Malovannaya A, Li S, Shao J, Roeder RG, Ellis MJ, Qin J, Fuqua SAW, O\u2019Malley BW, Foulds CE. Proteomic profiling identifies key coactivators utilized by mutant ER\u03b1 proteins as potential new therapeutic targets. Oncogene. 2018;37:4581\u201398. https:\/\/doi.org\/10.1038\/s41388-018-0284-2.","journal-title":"Oncogene"},{"key":"4434_CR67","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2021.07.010","volume":"520","author":"MV Yusenko","year":"2021","unstructured":"Yusenko MV, Biyanee A, Andersson MK, Radetzki S, von Kries JP, Stenman G, Klempnauer KH. Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner. Cancer Lett. 2021;520:132\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2021.07.010.","journal-title":"Cancer Lett"},{"key":"4434_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2020.01.039","volume":"479","author":"MV Yusenko","year":"2020","unstructured":"Yusenko MV, Trentmann A, Andersson MK, Ghani LA, Jakobs A, Arteaga Paz MF, Mikesch JH, von Peter J, Stenman G, Klempnauer KH. Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells. Cancer Lett. 2020;479:61\u201370. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.039.","journal-title":"Cancer Lett"},{"key":"4434_CR69","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20180939","volume":"215","author":"J Mandelbaum","year":"2018","unstructured":"Mandelbaum J, Shestopalov IA, Henderson RE, Chau NG, Knoechel B, Wick MJ, Zon LI. Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. J Exp Med. 2018;215:2673\u201385. https:\/\/doi.org\/10.1084\/jem.20180939.","journal-title":"J Exp Med"},{"key":"4434_CR70","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng.3502","volume":"48","author":"Y Drier","year":"2016","unstructured":"Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM, Afrogheh AH, Faquin WC, Queimado L, Qi J, Wick MJ, El-Naggar AK, Bradner JE, Moskaluk CA, Aster JC, Knoechel B, Bernstein BE. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016;48:265\u201372. https:\/\/doi.org\/10.1038\/ng.3502.","journal-title":"Nat Genet"},{"key":"4434_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cancergen.2022.03.002","volume":"264\u2013265","author":"G Harada","year":"2022","unstructured":"Harada G, Drilon A. TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults. Cancer Genet. 2022;264\u2013265:33\u20139. https:\/\/doi.org\/10.1016\/j.cancergen.2022.03.002.","journal-title":"Cancer Genet"},{"key":"4434_CR72","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15:731\u201347. https:\/\/doi.org\/10.1038\/s41571-018-0113-0.","journal-title":"Nat Rev Clin Oncol"},{"key":"4434_CR73","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1158\/2159-8290.Cd-16-1000","volume":"7","author":"L Goyal","year":"2017","unstructured":"Goyal L, Saha SK, Liu LY, Siravegna G, Leshchiner I, Ahronian LG, Lennerz JK, Vu P, Deshpande V, Kambadakone A, Mussolin B, Reyes S, Henderson L, Sun JE, Van Seventer EE, Gurski JM Jr., Baltschukat S, Schacher-Engstler B, Barys L, Stamm C, Furet P, Ryan DP, Stone JR, Iafrate AJ, Getz G, Porta DG, Tiedt R, Bardelli A, Juric D, Corcoran RB, Bardeesy N, Zhu AX. Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma. Cancer Discov. 2017;7:252\u201363. https:\/\/doi.org\/10.1158\/2159-8290.Cd-16-1000.","journal-title":"Cancer Discov"},{"key":"4434_CR74","doi-asserted-by":"publisher","first-page":"628690","DOI":"10.3389\/fphar.2021.628690","volume":"12","author":"C Dong","year":"2021","unstructured":"Dong C, Wu J, Chen Y, Nie J, Chen C. Activation of PI3K\/AKT\/mTOR Pathway Causes Drug Resistance in Breast Cancer. Front Pharmacol. 2021;12:628690. https:\/\/doi.org\/10.3389\/fphar.2021.628690.","journal-title":"Front Pharmacol"},{"key":"4434_CR75","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11684-015-0396-9","volume":"9","author":"PB Alexander","year":"2015","unstructured":"Alexander PB, Wang XF. Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies. Front Med. 2015;9:134\u20138. https:\/\/doi.org\/10.1007\/s11684-015-0396-9.","journal-title":"Front Med"},{"key":"4434_CR76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s40164-025-00718-4","volume":"14","author":"R Hablesreiter","year":"2025","unstructured":"Hablesreiter R, Strzelecka PM, Kopp K, Estrada N, Dolnik A, Tilgner M, Fustero-Torre C, Thol F, Heidel FH, Heuser M, Haghverdi L, Bullinger L, Christen F, Damm F. Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolution. Exp Hematol Oncol. 2025;14:127. https:\/\/doi.org\/10.1186\/s40164-025-00718-4.","journal-title":"Exp Hematol Oncol"},{"key":"4434_CR77","doi-asserted-by":"publisher","first-page":"e1786","DOI":"10.1093\/oncolo\/oyae226","volume":"29","author":"RB Keller-Evans","year":"2024","unstructured":"Keller-Evans RB, Munafo D, Ross T, Rudawsky S, Savol A, Huang RSP. Breadth versus depth: whole transcriptome sequencing has reduced sensitivity for detection of clinically relevant fusions compared to RNA comprehensive genomic profiling. Oncologist. 2024;29:e1786\u20139. https:\/\/doi.org\/10.1093\/oncolo\/oyae226.","journal-title":"Oncologist"},{"key":"4434_CR78","doi-asserted-by":"publisher","first-page":"582","DOI":"10.37349\/etat.2022.00102","volume":"3","author":"I Capone","year":"2022","unstructured":"Capone I, Bozzi F, Dagrada GP, Verderio P, Conca E, Busico A, Testi MA, Monti V, Duca M, Proto C, Damian S, Piccolo A, Perrone F, Tamborini E, Devecchi A, Collini P, Lorenzini D, Vingiani A, Agnelli L, Pruneri G. Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples. Explor Target Antitumor Ther. 2022;3:582\u201397. https:\/\/doi.org\/10.37349\/etat.2022.00102.","journal-title":"Explor Target Antitumor Ther"},{"key":"4434_CR79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00109-021-02149-0","volume":"100","author":"D Bergeron","year":"2022","unstructured":"Bergeron D, Chandok H, Nie Q, Prego M, Soucy M, Kelly K, Ananda G, Hesse A, Reddi HV. RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq\u2122 2.0 assay. J Mol Med (Berl). 2022;100:323\u201335. https:\/\/doi.org\/10.1007\/s00109-021-02149-0.","journal-title":"J Mol Med (Berl)"},{"key":"4434_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jmoldx.2020.11.005","volume":"23","author":"H Peng","year":"2021","unstructured":"Peng H, Huang R, Wang K, Wang C, Li B, Guo Y, Li M, Zhang D, Dong H, Chen H, Chen C, Xu Q, Li F, Tian L, Wu J. Development and Validation of an RNA Sequencing Assay for Gene Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tumors. J Mol Diagn. 2021;23:223\u201333. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.11.005.","journal-title":"J Mol Diagn"},{"key":"4434_CR81","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/onco.13880","volume":"26","author":"L Mortensen","year":"2021","unstructured":"Mortensen L, Ordulu Z, Dagogo-Jack I, Bossuyt V, Winters L, Taghian A, Smith BL, Ellisen LW, Kiedrowski LA, Lennerz JK, Bardia A, Spring LM. Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion. Oncologist. 2021;26:818\u201324. https:\/\/doi.org\/10.1002\/onco.13880.","journal-title":"Oncologist"},{"key":"4434_CR82","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378:731\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1714448.","journal-title":"N Engl J Med"},{"key":"4434_CR83","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/cac2.12425","volume":"43","author":"L Karimi","year":"2023","unstructured":"Karimi L, Alves CL, Terp MG, Tuttolomondo M, Portman N, Ehmsen S, Johansen LE, Bak M, Lim E, Ditzel HJ. Triple combination targeting PI3K, ER, and CDK4\/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4\/6 or PI3K inhibitor. Cancer Commun (Lond). 2023;43:720\u20135. https:\/\/doi.org\/10.1002\/cac2.12425.","journal-title":"Cancer Commun (Lond)"},{"key":"4434_CR84","doi-asserted-by":"publisher","first-page":"1037531","DOI":"10.3389\/fonc.2022.1037531","volume":"12","author":"Z Nagy","year":"2022","unstructured":"Nagy Z, Jeselsohn R. ESR1 fusions and therapeutic resistance in metastatic breast cancer. Front Oncol. 2022;12:1037531. https:\/\/doi.org\/10.3389\/fonc.2022.1037531.","journal-title":"Front Oncol"},{"key":"4434_CR85","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","volume":"25","author":"M Hinterndorfer","year":"2025","unstructured":"Hinterndorfer M, Spiteri VA, Ciulli A, Winter GE. Targeted protein degradation for cancer therapy. Nat Rev Cancer. 2025;25:493\u2013516. https:\/\/doi.org\/10.1038\/s41568-025-00817-8.","journal-title":"Nat Rev Cancer"},{"key":"4434_CR86","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/JTO.0b013e31821cfc73","volume":"6","author":"H Kim","year":"2011","unstructured":"Kim H, Yoo SB, Choe JY, Paik JH, Xu X, Nitta H, Zhang W, Grogan TM, Lee CT, Jheon S, Chung JH. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression. J Thorac Oncol. 2011;6:1359\u201366. https:\/\/doi.org\/10.1097\/JTO.0b013e31821cfc73.","journal-title":"J Thorac Oncol"},{"key":"4434_CR87","doi-asserted-by":"publisher","unstructured":"Chen Z, He X. (2021) Application of third-generation sequencing in cancer research. Med Rev (2021) 1:150\u2013171. https:\/\/doi.org\/10.1515\/mr-2021-0013","DOI":"10.1515\/mr-2021-0013"},{"key":"4434_CR88","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.xpro.2022.101185","volume":"3","author":"P Kim","year":"2022","unstructured":"Kim P, Tan H, Liu J, Kumar H, Zhou X. FusionAI, a DNA-sequence-based deep learning protocol reduces the false positives of human fusion gene prediction. STAR Protoc. 2022;3:101185. https:\/\/doi.org\/10.1016\/j.xpro.2022.101185.","journal-title":"STAR Protoc"},{"key":"4434_CR89","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12864-022-08339-5","volume":"23","author":"F Karaoglanoglu","year":"2022","unstructured":"Karaoglanoglu F, Chauve C, Hach F. Genion, an accurate tool to detect gene fusion from long transcriptomics reads. BMC Genomics. 2022;23:129. https:\/\/doi.org\/10.1186\/s12864-022-08339-5.","journal-title":"BMC Genomics"},{"key":"4434_CR90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13059-021-02588-5","volume":"23","author":"NM Davidson","year":"2022","unstructured":"Davidson NM, Chen Y, Sadras T, Ryland GL, Blombery P, Ekert PG, G\u00f6ke J, Oshlack A. JAFFAL: detecting fusion genes with long-read transcriptome sequencing. Genome Biol. 2022;23:10. https:\/\/doi.org\/10.1186\/s13059-021-02588-5.","journal-title":"Genome Biol"},{"key":"4434_CR91","doi-asserted-by":"publisher","first-page":"lqab112","DOI":"10.1093\/nargab\/lqab112","volume":"3","author":"R Detroja","year":"2021","unstructured":"Detroja R, Gorohovski A, Giwa O, Baum G, Frenkel-Morgenstern M. ChiTaH: a fast and accurate tool for identifying known human chimeric sequences from high-throughput sequencing data. NAR Genom Bioinform. 2021;3:lqab112. https:\/\/doi.org\/10.1093\/nargab\/lqab112.","journal-title":"NAR Genom Bioinform"},{"key":"4434_CR92","doi-asserted-by":"publisher","first-page":"739054","DOI":"10.3389\/fgene.2021.739054","volume":"12","author":"J Balan","year":"2021","unstructured":"Balan J, Jenkinson G, Nair A, Saha N, Koganti T, Voss J, Zysk C, Barr Fritcher EG, Ross CA, Giannini C, Raghunathan A, Kipp BR, Jenkins R, Ida C, Halling KC, Blackburn PR, Dasari S, Oliver GR, Klee EW. SeekFusion - A Clinically Validated Fusion Transcript Detection Pipeline for PCR-Based Next-Generation Sequencing of RNA. Front Genet. 2021;12:739054. https:\/\/doi.org\/10.3389\/fgene.2021.739054.","journal-title":"Front Genet"},{"key":"4434_CR93","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/bioinformatics\/btab249","volume":"37","author":"M Apostolides","year":"2021","unstructured":"Apostolides M, Jiang Y, Husi\u0107 M, Siddaway R, Hawkins C, Turinsky AL, Brudno M, Ramani AK. MetaFusion: a high-confidence metacaller for filtering and prioritizing RNA-seq gene fusion candidates. Bioinformatics. 2021;37:3144\u201351. https:\/\/doi.org\/10.1093\/bioinformatics\/btab249.","journal-title":"Bioinformatics"},{"key":"4434_CR94","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13059-020-02043-x","volume":"21","author":"L Tian","year":"2020","unstructured":"Tian L, Li Y, Edmonson MN, Zhou X, Newman S, McLeod C, Thrasher A, Liu Y, Tang B, Rusch MC, Easton J, Ma J, Davis E, Trull A, Michael JR, Szlachta K, Mullighan C, Baker SJ, Downing JR, Ellison DW, Zhang J. CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data. Genome Biol. 2020;21:126. https:\/\/doi.org\/10.1186\/s13059-020-02043-x.","journal-title":"Genome Biol"},{"key":"4434_CR95","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1093\/bioinformatics\/btaa069","volume":"36","author":"M Lovino","year":"2020","unstructured":"Lovino M, Ciaburri MS, Urgese G, Di Cataldo S, Ficarra E. DEEPrior: a deep learning tool for the prioritization of gene fusions. Bioinformatics. 2020;36:3248\u201350. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa069.","journal-title":"Bioinformatics"},{"key":"4434_CR96","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12864-020-07207-4","volume":"21","author":"Q Liu","year":"2020","unstructured":"Liu Q, Hu Y, Stucky A, Fang L, Zhong JF, Wang K. LongGF: computational algorithm and software tool for fast and accurate detection of gene fusions by long-read transcriptome sequencing. BMC Genomics. 2020;21:793. https:\/\/doi.org\/10.1186\/s12864-020-07207-4.","journal-title":"BMC Genomics"},{"key":"4434_CR97","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12859-020-03922-7","volume":"21","author":"KS Gaonkar","year":"2020","unstructured":"Gaonkar KS, Marini F, Rathi KS, Jain P, Zhu Y, Chimicles NA, Brown MA, Naqvi AS, Zhang B, Storm PB, Maris JM, Raman P, Resnick AC, Strauch K, Taroni JN, Rokita JL. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions. BMC Bioinformatics. 2020;21:577. https:\/\/doi.org\/10.1186\/s12859-020-03922-7.","journal-title":"BMC Bioinformatics"},{"key":"4434_CR98","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1093\/bioinformatics\/btz902","volume":"36","author":"R Chiu","year":"2020","unstructured":"Chiu R, Nip KM, Birol I. Fusion-Bloom: fusion detection in assembled transcriptomes. Bioinformatics. 2020;36:2256\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btz902.","journal-title":"Bioinformatics"},{"key":"4434_CR99","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.5808\/GI.2019.17.3.e26","volume":"17","author":"P Kim","year":"2019","unstructured":"Kim P, Jang YE, Lee S. FusionScan: accurate prediction of fusion genes from RNA-Seq data. Genomics Inf. 2019;17:e26. https:\/\/doi.org\/10.5808\/GI.2019.17.3.e26.","journal-title":"Genomics Inf"},{"key":"4434_CR100","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1093\/bioinformatics\/bty1070","volume":"35","author":"L Jin","year":"2019","unstructured":"Jin L, Lai J, Zhang Y, Fu Y, Wang S, Dai H, Huang B. BreakID: genomics breakpoints identification to detect gene fusion events using discordant pairs and split reads. Bioinformatics. 2019;35:2859\u201361. https:\/\/doi.org\/10.1093\/bioinformatics\/bty1070.","journal-title":"Bioinformatics"},{"key":"4434_CR101","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12864-018-5156-1","volume":"19","author":"TN Vu","year":"2018","unstructured":"Vu TN, Deng W, Trac QT, Calza S, Hwang W, Pawitan Y. A fast detection of fusion genes from paired-end RNA-seq data. BMC Genomics. 2018;19:786. https:\/\/doi.org\/10.1186\/s12864-018-5156-1.","journal-title":"BMC Genomics"},{"key":"4434_CR102","doi-asserted-by":"publisher","first-page":"843","DOI":"10.7150\/ijbs.24626","volume":"14","author":"S Chen","year":"2018","unstructured":"Chen S, Liu M, Huang T, Liao W, Xu M, Gu J. GeneFuse: detection and visualization of target gene fusions from DNA sequencing data. Int J Biol Sci. 2018;14:843\u20138. https:\/\/doi.org\/10.7150\/ijbs.24626.","journal-title":"Int J Biol Sci"},{"key":"4434_CR103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12864-016-3404-9","volume":"18","author":"B Rodr\u00edguez-Mart\u00edn","year":"2017","unstructured":"Rodr\u00edguez-Mart\u00edn B, Palumbo E, Marco-Sola S, Griebel T, Ribeca P, Alonso G, Rastrojo A, Aguado B, Guig\u00f3 R, Djebali S. ChimPipe: accurate detection of fusion genes and transcription-induced chimeras from RNA-seq data. BMC Genomics. 2017;18:7. https:\/\/doi.org\/10.1186\/s12864-016-3404-9.","journal-title":"BMC Genomics"},{"key":"4434_CR104","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12859-016-1450-6","volume":"18","author":"G Paciello","year":"2017","unstructured":"Paciello G, Ficarra E. FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples. BMC Bioinformatics. 2017;18:58. https:\/\/doi.org\/10.1186\/s12859-016-1450-6.","journal-title":"BMC Bioinformatics"},{"key":"4434_CR105","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1093\/nar\/gkx315","volume":"45","author":"Y Li","year":"2017","unstructured":"Li Y, Heavican TB, Vellichirammal NN, Iqbal J, Guda C. ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data. Nucleic Acids Res. 2017;45:e120. https:\/\/doi.org\/10.1093\/nar\/gkx315.","journal-title":"Nucleic Acids Res"},{"key":"4434_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fgene.2017.00137","volume":"8","author":"Z Huang","year":"2017","unstructured":"Huang Z, Jones DTW, Wu Y, Lichter P, Zapatka M. confFuse: High-Confidence Fusion Gene Detection across Tumor Entities. Front Genet. 2017;8:137. https:\/\/doi.org\/10.3389\/fgene.2017.00137.","journal-title":"Front Genet"},{"key":"4434_CR107","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1093\/nar\/gkx453","volume":"45","author":"G Hsieh","year":"2017","unstructured":"Hsieh G, Bierman R, Szabo L, Lee AG, Freeman DE, Watson N, Sweet-Cordero EA, Salzman J. Statistical algorithms improve accuracy of gene fusion detection. Nucleic Acids Res. 2017;45:e126. https:\/\/doi.org\/10.1093\/nar\/gkx453.","journal-title":"Nucleic Acids Res"},{"key":"4434_CR108","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1101\/gr.186114.114","volume":"26","author":"J Zhang","year":"2016","unstructured":"Zhang J, White NM, Schmidt HK, Fulton RS, Tomlinson C, Warren WC, Wilson RK, Maher CA. INTEGRATE: gene fusion discovery using whole genome and transcriptome data. Genome Res. 2016;26:108\u201318. https:\/\/doi.org\/10.1101\/gr.186114.114.","journal-title":"Genome Res"},{"key":"4434_CR109","doi-asserted-by":"publisher","first-page":"e0167417","DOI":"10.1371\/journal.pone.0167417","volume":"11","author":"K Okonechnikov","year":"2016","unstructured":"Okonechnikov K, Imai-Matsushima A, Paul L, Seitz A, Meyer TF, Garcia-Alcalde F. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data. PLoS ONE. 2016;11:e0167417. https:\/\/doi.org\/10.1371\/journal.pone.0167417.","journal-title":"PLoS ONE"},{"key":"4434_CR110","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/jcp.2009.073908","volume":"63","author":"C Marchi\u00f2","year":"2010","unstructured":"Marchi\u00f2 C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or \u2018The strange case of Dr Jekyll and Mr Hyde\u2019 of exocrine gland carcinomas). J Clin Pathol. 2010;63:220\u20138. https:\/\/doi.org\/10.1136\/jcp.2009.073908.","journal-title":"J Clin Pathol"},{"key":"4434_CR111","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1038\/nature14265","volume":"520","author":"JM Mosquera","year":"2015","unstructured":"Mosquera JM, Varma S, Pauli C, MacDonald TY, Yashinskie JJ, Varga Z, Sboner A, Moch H, Rubin MA, Shin SJ. MAGI3-AKT3 fusion in breast cancer amended. Nature. 2015;520:E11\u20132. https:\/\/doi.org\/10.1038\/nature14265.","journal-title":"Nature"},{"key":"4434_CR112","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21873\/cgp.20184","volume":"17","author":"I Panagopoulos","year":"2020","unstructured":"Panagopoulos I, Gorunova L, Andersen K, Lund-Iversen M, Lobmaier I, Micci F, Heim S. NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma. Cancer Genomics Proteom. 2020;17:237\u201348. https:\/\/doi.org\/10.21873\/cgp.20184.","journal-title":"Cancer Genomics Proteom"},{"key":"4434_CR113","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1158\/1078-0432.Ccr-13-0295","volume":"19","author":"JS Ross","year":"2013","unstructured":"Ross JS, Wang K, Sheehan CE, Boguniewicz AB, Otto G, Downing SR, Sun J, He J, Curran JA, Ali S, Yelensky R, Lipson D, Palmer G, Miller VA, Stephens PJ. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations. Clin Cancer Res. 2013;19:2668\u201376. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-0295.","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04434-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04434-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04434-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:48:15Z","timestamp":1789195695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04434-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4434"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04434-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"311"}}